Clover Health Investments: Q2 Earnings Insights

  Clover Health Investments (NASDAQ:CLOV) reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

 

Clover Health Investments (NASDAQ:CLOV) reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

Clover Health Investments missed estimated earnings by 4.76%, reporting an EPS of $-0.22 versus an estimate of $-0.21.

Revenue was up $434.23 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.09 which was followed by a 1.66% drop in the share price the next day.

Here’s a look at Clover Health Investments’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.25 -0.26 -0.23 -0.13
EPS Actual -0.16 -0.44 -0.08 -0.78
Revenue Estimate 787.34M 408.14M 413.10M 205.38M
Revenue Actual 874.38M 432.04M 427.16M 412.47M

To track all earnings releases for Clover Health Investments visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Snap Stock Falters As Growth Slows To Record Low

- Revenue came in at $1.11 billion missing estimates of $1.14 billion by analysts. Revenue grew by 13% y-o-y, the slowest on record. - Earnings per share came in at -26 cents versus -10 cents during the same quarter in 2021. - Adjusted EBITDA came in at $7.19 million, meanwhile unadjusted losses came in at $1.24 million.

SNAP